Login

Mahary Lalarizo Rakoto

ORCID: 0000-0002-0128-352X
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
A5028275867
Research Areas
  • SARS-CoV-2 and COVID-19 Research
  • COVID-19 Clinical Research Studies
  • SARS-CoV-2 detection and testing
  • Long-Term Effects of COVID-19
  • Malaria Research and Control
  • Essential Oils and Antimicrobial Activity
  • Monoclonal and Polyclonal Antibodies Research
  • Ethnobotanical and Medicinal Plants Studies

Centre Hospitalier Universitaire de La Réunion
 2021-2022

University of Antananarivo
 2020-2022

Pharmac
 2021

Observatoire des Sciences de l'Univers de la Réunion
 2020

 Robust and low-cost ELISA based on IgG-Fc tagged recombinant proteins to screen for anti-SARS-CoV-2 antibodies
OPENALEX - Publications 
Étienne Frumence Grégorie Lebeau Wildriss Viranaïcken Anthony Dobi Damien Vagner and 6 more Mahary Lalarizo Rakoto Anne-Laure Sandenon Seteyen Claude Giry Axelle Septembre‐Malaterre L. Raffray Philippe Gasque

10.1016/j.jim.2021.113082 article EN publisher-specific-oa Journal of Immunological Methods 2021-05-26
 Low levels of the key B cell activation marker, HLA-DR, in COVID-19 hospitalized cases are associated with disease severity, dexamethasone treatment, and circulating IL-6 levels
OPENALEX - Publications 
Anthony Dobi Arthur Dubernet Mahary Lalarizo Rakoto Anne-Laure Sandenon Seteyen Damien Vagner and 3 more Grégorie Lebeau L. Raffray Philippe Gasque

10.1007/s12026-022-09269-w article EN Immunologic Research 2022-06-09
 Serological Surveillance of COVID-19 Hospitalized Patients in Réunion Island (France) Revealed that Specific Immunoglobulin G Are Rapidly Vanishing in Severe Cases
OPENALEX - Publications 
Anthony Dobi Anne-Laure Sandenon Seteyen Mahary Lalarizo Rakoto Grégorie Lebeau Damien Vagner and 5 more Étienne Frumence Claude Giry Axelle Septembre‐Malaterre L. Raffray Philippe Gasque

Humoral immunity is critically important to control COVID-19. Long-term antibody responses remain be fully characterized in hospitalized patients who have a high risk of death. We compared specific Immunoglobulin against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) between two groups, intensive care unit (ICU) and non-ICU over several weeks. Plasma IgG, IgM, IgA levels were assessed using commercial ELISA an in-house cell-based ELISA. Among the analyzed (mean (SD) age, 64.4...

10.3390/jcm9123847 article EN Journal of Clinical Medicine 2020-11-27
Coming Soon ...